Compound medicine for preventing and treating porcine reproductive and respiratory syndrome

A technology for porcine blue-ear disease and drugs, applied in drug delivery, antiviral agents, pharmaceutical formulations, etc., to improve survival rate and alleviate clinical symptoms

Pending Publication Date: 2022-01-04
BEIJING DABEINONG ANIMAL HEALTH TECH +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no relevant report showing that Houttuyfonate Sodium and Mannan Peptide can effectively treat PRRS

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound medicine for preventing and treating porcine reproductive and respiratory syndrome
  • Compound medicine for preventing and treating porcine reproductive and respiratory syndrome
  • Compound medicine for preventing and treating porcine reproductive and respiratory syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] prescription:

[0021] prescription ingredients Prescription amount Tilmicosin 400g Sodium Houttuyniatin 50g mannan peptide 50g starch 500g

[0022] Preparation:

[0023] Weigh the prescribed amount of tilmicosin, houttuyfonate sodium, mannan peptide, and starch, and mix them evenly to obtain the powder of the drug.

Embodiment 2

[0025] prescription:

[0026] prescription ingredients Prescription amount Tylosin tartrate 800g Sodium Houttuyniatin 10g mannan peptide 10g corn cob flour 180g

[0027] Preparation:

[0028] The prescribed amount of tylosin tartrate, houttuyfonate sodium, mannan peptide, and corn cob powder is weighed and mixed evenly to obtain a drug premix.

Embodiment 3

[0030] prescription:

[0031] prescription ingredients Prescription amount Tylvalosin tartrate 600g Sodium Houttuyniatin 100g mannan peptide 100g dextrin 200g

[0032] Preparation:

[0033] Weigh the prescribed amount of tyvalactin tartrate, sodium houttuyfonate, mannan peptide, and dextrin, mix them uniformly, make soft materials, granulate, and dry to obtain the granules of the medicine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a compound medicine for preventing and treating porcine reproductive and respiratory syndrome, and belongs to the field of veterinary medicines. The compound medicine is an oral pharmaceutical preparation prepared from macrolide medicines special for animals, sodium houttuyfonate, mannatide and pharmaceutical adjuvants in a certain proportion. The medicine disclosed by the invention can be used for effectively treating acute-stage porcine reproductive and respiratory syndrome, rapidly relieving clinical symptoms of diseased pigs and improving survival rate.

Description

technical field [0001] The invention belongs to the field of veterinary drugs, in particular to a compound drug for preventing and treating pig blue-ear disease. Background technique [0002] Porcine blue ear disease (PRRSV) is a highly contagious disease with endemicity. PRRSV only infects pigs, and pigs of various breeds, ages and uses can be infected, but pregnant sows and piglets within 1 month are most susceptible. [0003] After porcine PRRS virus invades the pig body, it will cause damage to the immune system of various parts of the pig body, especially to the cultivation of porcine alveolar macrophages. Thereby causing other complications, such as fibrinous serositis and arthritis and paratyphoid and other diseases. Simultaneously, the destruction of the immune system makes the effect of vaccination unable to be brought into play, which seriously restricts the output and quality of pigs. After pigs are infected with this virus, the virus stays in the body for a lo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/16A61K31/706A61K31/7048A61K31/7052A61K31/185A61K9/00A61P31/14
CPCA61K38/164A61K31/706A61K31/7048A61K31/7052A61K31/185A61K9/0095A61P31/14A61K2300/00
Inventor 田玲刘澜张元勇卢贵梅
Owner BEIJING DABEINONG ANIMAL HEALTH TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap